A Multiple Dose Study of DWP05195 in Healthy Adult Subjects
NCT01094834 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2011-02-09
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of multiple administered DWP05195 in healthy volunteers
Conditions
- Healthy Adult Volunteers
Interventions
- DRUG
-
DWP05195
tablets, oral administration, multiple administration
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-10-31
More Related Trials
-
Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
NCT01522586 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean
NCT03574415 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
NCT04524052 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C
NCT05465668 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults
NCT04966832 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
NCT04592835 ·Status: UNKNOWN ·Phase: PHASE1
-
A Single Dose Study of DWP10292 in Healthy Male Subjects
NCT01423526 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers
NCT05195723 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers
NCT05433844 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
NCT04749173 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects
NCT01284036 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
NCT01952548 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects
NCT07007533 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809
NCT05214677 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
NCT04477369 ·Status: UNKNOWN ·Phase: PHASE1
-
The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
NCT05607589 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers
NCT01288196 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers
NCT02097043 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers
NCT04021563 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults
NCT06469151 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults
NCT04479865 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)
NCT04938752 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers
NCT05784155 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers
NCT03979859 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
NCT01476046 ·Status: COMPLETED ·Phase: PHASE1